Category Archives: Company News

International Hypertension Program Launch

Medical Device clinical study in treatment of uncontrolled hypertension – an international program launch AmeRuss recently executed an agreement with a medical device firm within  an international consortium of companies to conduct a clinical trial in patients with uncontrolled hypertension. The 2 year study will combine efforts of sites in Russia, Belgium, Germany, Hungary, Ireland, Israel,...
more

Phase III study – Acute Bronchitis submitted for approval in Russia

A randomized prospective comparative, open, parallel group clinical study of the efficacy and safety of film-coated pills and oral solution of investigational drug in adults with acute bronchitis has recently been submitted to the Russian Ministry of Health for approval. AmeRuss is providing full-service regulatory and investigational support including performance of all necessary regulatory activities, submissions...
more

Interim analysis enrollment target reached on time in Phase II breast cancer study

AmeRuss is happy to announce that the global enrollment of the study of approved combination of study drugs for the treatment of patients with human epidermal growth factor receptor 2 (HER2)-positive breast cancer which has progressed following prior therapy reached its interim analysis milestone on time. This is an open label, randomized, multicenter, phase II study...
more

Enrollment goal reached in cardiology device study

AmeRuss is pleased to announce that 238 patients were enrolled recently in an international cardiology medical device study. This study of the efficacy and safety of sirolimus coronary stent as compared to the everolimus coronary stent  is a prospective, randomized, multicenter trial. AmeRuss Clinical Trials, LLC is providing full regulatory and investigational support including performance of all...
more

Patients with cardiac pacemakers- Remote Monitoring Technology

Advances in information and telecommunication technology has led to the birth of a radically new medical service based on the remote mobile monitoring of patients with implanted pacemakers, defibrillators, or cardiac resynchronization devices. This medical device study managed by AmeRuss is designed to evaluate clinical and economic benefits from monitoring of the patient`s condition with the...
more

Global enrollment goal reached in Phase II Severe Asthma Study

Nov 2015. The global enrollment goal of 544 subjects in this study has been reached. The aim of the study is to evaluate the efficacy and safety of mepolizumab adjunctive therapy on markers of asthma control in subjects with severe eosinophilic asthma. The international study is a randomized, double-blind, placebo-controlled, parallel-group, multi-center. Recruitment for the study has...
more